The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Philipp le Coutre

Medizinische Klinik m.S. Hämatologie und Onkologie

Charité -Universitätsmedizin Berlin

Campus Virchow-Klinikum

Augustenburger Platz 1



Name/email consistency: high



  • Medizinische Klinik m.S. Hämatologie und Onkologie, Charité -Universitätsmedizin Berlin, Campus Virchow-Klinikum, Augustenburger Platz 1, Germany. 2009 - 2012
  • Campus Virchow Klinikum, Charité Universitätsmedizin, Berlin, Germany. 2008 - 2010


  1. Clinical cardiac safety profile of nilotinib. Kim, T.D., le Coutre, P., Schwarz, M., Grille, P., Levitin, M., Fateh-Moghadam, S., Giles, F.J., Dörken, B., Haverkamp, W., Köhncke, C. Haematologica (2012) [Pubmed]
  2. Severe peripheral arterial disease during nilotinib therapy. Le Coutre, P., Rea, D., Abruzzese, E., Dombret, H., Trawinska, M.M., Herndlhofer, S., Dörken, B., Valent, P. J. Natl. Cancer Inst. (2011) [Pubmed]
  3. BCR-ABL positive cells and chronic myeloid leukemia in immune suppressed organ transplant recipients. le Coutre, P., Reinke, P., Neuhaus, R., Trappe, R., Ringel, F., Lalancette, M., Hemmati, P.G., Dörken, B., Daniel, P.T. Eur. J. Haematol. (2010) [Pubmed]
  4. New developments in tyrosine kinase inhibitor therapy for newly diagnosed chronic myeloid leukemia. le Coutre, P., Schwarz, M., Kim, T.D. Clin. Cancer Res. (2010) [Pubmed]
  5. Nilotinib. Quintás-Cardama, A., Kim, T.D., Cataldo, V., le Coutre, P. Recent Results Cancer Res. (2010) [Pubmed]
  6. Reactivation of hepatitis E infection in a patient with acute lymphoblastic leukaemia after allogeneic stem cell transplantation. le Coutre, P., Meisel, H., Hofmann, J., Röcken, C., Vuong, G.L., Neuburger, S., Hemmati, P.G., Dörken, B., Arnold, R. Gut (2009) [Pubmed]
  7. Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is active in patients with imatinib-resistant or -intolerant accelerated-phase chronic myelogenous leukemia. le Coutre, P., Ottmann, O.G., Giles, F., Kim, D.W., Cortes, J., Gattermann, N., Apperley, J.F., Larson, R.A., Abruzzese, E., O'Brien, S.G., Kuliczkowski, K., Hochhaus, A., Mahon, F.X., Saglio, G., Gobbi, M., Kwong, Y.L., Baccarani, M., Hughes, T., Martinelli, G., Radich, J.P., Zheng, M., Shou, Y., Kantarjian, H. Blood (2008) [Pubmed]
WikiGenes - Universities